| Name | Triacetylganciclovir |
|---|---|
| Synonyms |
[2-[(2-acetamido-6-oxo-3H-purin-9-yl)methoxy]-3-acetyloxypropyl] acetate
2-[(2-Acetamido-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]-1,3-propanediyl diacetate Acetamide, N-[9-[[2-(acetyloxy)-1-[(acetyloxy)methyl]ethoxy]methyl]-6,9-dihydro-6-oxo-1H-purin-2-yl]- T56 BN DN FN HNJ D1OY1OV1&1OV1 GMV1 IQ T56 BN DN FVM INJ B1OY1OV1&1OV1 HMV1 N-[9-[[2-(Acetyloxy)-1-[(acetyloxy)methyl]ethoxy]methyl]-6,9-dihydro-6-oxo-1H-purin-2-yl]acetamide |
| Description | Triacetyl-ganciclovir is a Ganciclovir derivative. Ganciclovir is an orally active antiviral agent with activity against cytomegalovirus (CMV)[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Melting Point | 174 °C |
| Molecular Formula | C15H19N5O7 |
| Molecular Weight | 381.34 |
| Exact Mass | 381.128448 |
| PSA | 154.50000 |
| LogP | -0.78 |
| Index of Refraction | 1.629 |
| Storage condition | 2~8°C |
| Hazard Codes | Xi |
|---|
|
~50%
86357-14-4 |
| Literature: Boryski, Jerzy; Golankiewicz, Bozenna Synthesis, 1999 , # 4 p. 625 - 628 |
|
~%
86357-14-4 |
| Literature: Synthesis, , # 4 p. 625 - 628 |